Demographics | Number = 24 |
Median age (range) <40 years ≥40 years | 37 years (18 - 60) 13 (54.17%) 11 (45.83%) |
Pregnancy status Median <4 ≥4 |
5 7 (29.16%) 17 (70.84%) |
Antecedent pregnancy Hydatidiform mole Abortion Term pregnancy |
18 (75.00%) 4 (16.67%) 2 (8.33%) |
Interval <6 months 7 - 12 months >12 months Unknown |
14 (58.20%) 2 (8.33%) 5 (20.83%) 3 (12.50%) |
Pre-treatment HCG level <1000 1000 - <10,000 10,000 - <100,000 ≥100,000 |
6 (25.00%) 4 (16.67%) 7 (29.17%) 7 (29.10%) |
Clinico-pathologic type Persistent/invasive GTN Choriocarcinoma |
5 (20.83%) 19 (79.17%) |
Tumor size <4 centimeters (cm) >5 centimeters (cm) Unknown |
8 (33.33%) 8 (33.33%) 8 (33.33%) |
FIGO stage I II III IV |
4 (16.60%) 7 (29.17%) 5 (20.83%) 8 (33.33%) |
Radiation therapy No |
24 (100%) |
Surgery Uterine evacuation Hysterectomy Metastasectomy |
22 (91.66%) 2 (8.33%) 0 (0.00%) |
Chemotherapy Single agent Methotrexate Combination chemotherapy No chemotherapy |
10 (41.66%) 9 (37.50%) 5 (20.83%) |